Report Code : CVMI0602202501 | Published Date : June 4, 2025
1 | Market Overview
The global fecal occult blood testing (FOBT) market plays a pivotal role in the early detection of colorectal cancer (CRC), gastrointestinal bleeding, and other occult gastrointestinal disorders. FOBT is a non-invasive, low-cost, and widely accepted screening tool used to detect hidden (occult) blood in the stool. The market consists of two major test types: guaiac-based fecal occult blood tests (gFOBT) and fecal immunochemical tests (FIT/iFOBT), with FIT gradually gaining market dominance due to its higher sensitivity, specificity, and patient compliance.
Colorectal cancer ranks among the leading causes of cancer-related deaths worldwide. With increasing screening initiatives, aging populations, and improved public awareness, FOBT has emerged as a key frontline tool in preventive healthcare. Technological advancements such as automated analyzers, point-of-care FIT kits, and AI-supported stool sample interpretation are further boosting adoption.
2 | Market Size and Forecast
Year |
Market Value (USD billion) |
Notes |
2019 |
1.25 |
Based on CRC screening programs and hospital procurement |
2024 |
1.93 |
Five-year CAGR: 8.9% |
2031 |
3.89 |
Seven-year CAGR: 10.7% |
The market is expected to double by 2031, driven by government-backed screening mandates, increased CRC prevalence, and innovations in sample collection and automation.
3 | Primary Market Drivers
- Rising colorectal cancer incidence globally
- Government and NGO-led screening initiatives
- Higher adoption of immunochemical (FIT) tests over guaiac-based tests
- Availability of home testing kits improving compliance
- Integration of FOBT in national health screening programs (e.g., USA, UK, Japan, Australia)
4 | Market Challenges
- False positives and need for follow-up colonoscopy
- Limited awareness in developing countries
- Compliance issues with multi-sample protocols
- Competition from more comprehensive DNA-based stool tests
- Reimbursement variability across regions
5 | Competitive Landscape
Company |
Est. 2024 Share |
Strengths |
Recent Strategic Move |
QuidelOrtho Corporation |
14% |
Broad diagnostics portfolio with CLIA-waived FIT kits |
Launched QuickVue® One FIT+ platform for home use |
Sysmex Corporation |
12% |
High-throughput immunochemical analyzers |
Expanded screening reach in APAC via government tenders |
Polymedco |
10% |
Dedicated to colorectal cancer screening programs |
Secured multi-state FIT contracts in the U.S. |
Eiken Chemical Co., Ltd. |
9% |
High-sensitivity OC-Sensor family of analyzers |
Added new sample prep systems for national screening labs |
Abbott Laboratories |
8% |
Automation-integrated immunoassays |
Expanded FOBT menu within Alinity i platform |
6 | Detailed Market Segmentation
By Test Type
- Fecal Immunochemical Test (FIT/iFOBT): 72%
- Guaiac-based FOBT (gFOBT): XX%
By Sample Type
- Single Sample
- Multiple Sample (2–3 samples)
By End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Ambulatory Surgical Centers
- Home Healthcare Settings
By Region
- North America – 41% (most mature screening infrastructure)
- Europe – XX%
- Asia-Pacific – fastest growth driven by population-level CRC programs
- Latin America & MEA – moderate adoption with public screening pilot programs
7 | Technology and Innovation
- Automated FIT analyzers for central laboratories
- Self-contained stool collection devices for home testing
- AI-assisted sample image interpretation
- Digital follow-up and compliance apps
- Multiplex testing platforms combining CRC and GI infection panels
8 | Regulatory Environment
- FDA 510(k) clearance for FIT kits and sample collectors
- CE Marking under IVDR in Europe
- Japan and South Korea national health insurance coverage for FOBT
- CMS guidelines in the U.S. for CRC screening reimbursement every 12 months
- WHO screening framework support in LMICs
9 | Strategic Outlook
- Companies should invest in user-friendly home kits with mobile app integration to boost patient adherence.
- Public-private partnerships with health ministries will drive volume in developing countries.
- Multiplexing FOBT with DNA or infection markers will differentiate offerings.
- Reimbursement advocacy and patient awareness campaigns are essential to penetrate underserved populations.
- Integration with EHR systems and follow-up reminder platforms will support longitudinal screening success.
Reasons To Buy

Scope

- Abbott Laboratories
- Beckman Coulter Inc.
- Fujirebio Diagnostics Inc.
- Sysmex Corporation
- Roche Diagnostics
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories Inc.
- Eiken Chemical Co. Ltd.
- Epigenomics AG
- Polymedco Inc.
- Randox Laboratories Ltd.
- Siemens Healthineers AG
Global Fecal Occult Testing Market Report
- 1. Global Fecal Occult Testing Market Research Report
- 1.1 Study Objectives
- 1.2 Global Fecal Occult Testing Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2. Global Fecal Occult Testing Market Research Report - Preface
- 2.1 Global Fecal Occult Testing Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Test Type
- 2.1.2 By Sample Collection Method
- 2.1.3 By End User
- 2.1.4 By Test Mode
- 2.1.5 By Age Group
- 2.1.6 By Region
- 2.1 Global Fecal Occult Testing Market Research Report – Detailed Scope and Definitions
- 3. Global Fecal Occult Testing Market Dynamics
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, By Country
- 3.3. Opportunities – By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, By Country
- 3.4. Trends – By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Fecal Occult Testing Market Research Report – DROTs Impact Analysis
-
- 4. Global Fecal Occult Testing Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5. Global Fecal Occult Testing Market, By Test Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 5.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Single-Sample Test Kits
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Multiple-Sample Test Kits
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Diagnostic Laboratories
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Ambulatory Surgical Centers
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.4 Home Care Settings
- 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Laboratory-Based Tests
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Point-of-Care Tests
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Home-Based Test Kits
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 Below 40 Years
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 40–60 Years
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Above 60 Years
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10. Global Fecal Occult Testing Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
- 10.1 North America
- 10.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 10.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 10.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 10.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 10.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 10.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 10.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 10.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 10.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 10.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 10.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 10.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 10.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 10.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 10.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 10.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 10.1 North America
- 11. North America Global Fecal Occult Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
- 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 11.1.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 11.1.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 11.2.1 Single-Sample Test Kits
- 11.2.2 Multiple-Sample Test Kits
- 11.3.1 Hospitals
- 11.3.2 Diagnostic Laboratories
- 11.3.3 Ambulatory Surgical Centers
- 11.3.4 Home Care Settings
- 11.4.1 Laboratory-Based Tests
- 11.4.2 Point-of-Care Tests
- 11.4.3 Home-Based Test Kits
- 11.5.1 Below 40 Years
- 11.5.2 40–60 Years
- 11.5.3 Above 60 Years
- 11.6.1 USA
- 11.6.2 Canada
- 11.6.3 Mexico
- 11.7 North America Global Fecal Occult Testing Market – Opportunity Analysis Index, By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, and Country, 2024 - 2031
- 11.8 Regional Trends Analysis
- 11.9 North America Global Fecal Occult Testing Market Research Report - Company Profiles
- 11.9.1 Company 1 (USA)
- 11.9.2 Company 2 (Canada)
- 11.9.3 Company 3 (Canada)
- 12.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 12.1.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 12.1.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 12.2.1 Single-Sample Test Kits
- 12.2.2 Multiple-Sample Test Kits
- 12.3.1 Hospitals
- 12.3.2 Diagnostic Laboratories
- 12.3.3 Ambulatory Surgical Centers
- 12.3.4 Home Care Settings
- 12.4.1 Laboratory-Based Tests
- 12.4.2 Point-of-Care Tests
- 12.4.3 Home-Based Test Kits
- 12.5.1 Below 40 Years
- 12.5.2 40–60 Years
- 12.5.3 Above 60 Years
- 12.6.1 Brazil
- 12.6.2 Argentina
- 12.6.3 Colombia
- 12.6.4 Chile
- 12.6.5 Rest of Latin America
- 12.7 Latin America Global Fecal Occult Testing Market – Opportunity Analysis Index, By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, and Country, 2024 - 2031
- 12.8 Regional Trends Analysis
- 12.9 Latin America Global Fecal Occult Testing Market Research Report - Company Profiles
- 12.9.1 Company 1 (Brazil)
- 12.9.2 Company 2 (Argentina)
- 12.9.3 Company 3 (Argentina)
- 13.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 13.1.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 13.1.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 13.2.1 Single-Sample Test Kits
- 13.2.2 Multiple-Sample Test Kits
- 13.3.1 Hospitals
- 13.3.2 Diagnostic Laboratories
- 13.3.3 Ambulatory Surgical Centers
- 13.3.4 Home Care Settings
- 13.4.1 Laboratory-Based Tests
- 13.4.2 Point-of-Care Tests
- 13.4.3 Home-Based Test Kits
- 13.5.1 Below 40 Years
- 13.5.2 40–60 Years
- 13.5.3 Above 60 Years
- 13.6.1 Germany
- 13.6.2 United Kingdom
- 13.6.3 France
- 13.6.4 Italy
- 13.6.5 Spain
- 13.6.6 Netherlands
- 13.6.7 Sweden, Switzerland, Russia, and Rest of Europe
- 13.7 Europe Global Fecal Occult Testing Market – Opportunity Analysis Index, By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, and Country, 2024 - 2031
- 13.8 Regional Trends Analysis
- 13.9 Europe Global Fecal Occult Testing Market Research Report - Company Profiles
- 13.9.1 Company 1 (Germany)
- 13.9.2 Company 2 (United Kingdom)
- 13.9.3 Company 3 (United Kingdom)
- 14.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 14.1.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 14.1.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 14.2.1 Single-Sample Test Kits
- 14.2.2 Multiple-Sample Test Kits
- 14.3.1 Hospitals
- 14.3.2 Diagnostic Laboratories
- 14.3.3 Ambulatory Surgical Centers
- 14.3.4 Home Care Settings
- 14.4.1 Laboratory-Based Tests
- 14.4.2 Point-of-Care Tests
- 14.4.3 Home-Based Test Kits
- 14.5.1 Below 40 Years
- 14.5.2 40–60 Years
- 14.5.3 Above 60 Years
- 14.6.1 Japan
- 14.6.2 China
- 14.6.3 India
- 14.6.4 South Korea
- 14.6.5 Australia & NZ
- 14.6.6 ASEAN
- 14.6.7 Rest of Asia-Pacific
- 14.7 Asia-Pacific Global Fecal Occult Testing Market – Opportunity Analysis Index, By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, and Country, 2024 - 2031
- 14.8 Regional Trends Analysis
- 14.9 Asia-Pacific Global Fecal Occult Testing Market Research Report - Company Profiles
- 14.9.1 Company 1 (Japan)
- 14.9.2 Company 2 (China)
- 14.9.3 Company 3 (China)
- 15.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 15.1.1 Guaiac-Based Fecal Occult Blood Test (gFOBT)
- 15.1.2 Immunochemical Fecal Occult Blood Test (iFOBT or FIT)
- 15.1.3 Fecal DNA Tests (FIT-DNA or Stool DNA)
- 15.2.1 Single-Sample Test Kits
- 15.2.2 Multiple-Sample Test Kits
- 15.3.1 Hospitals
- 15.3.2 Diagnostic Laboratories
- 15.3.3 Ambulatory Surgical Centers
- 15.3.4 Home Care Settings
- 15.4.1 Laboratory-Based Tests
- 15.4.2 Point-of-Care Tests
- 15.4.3 Home-Based Test Kits
- 15.5.1 Below 40 Years
- 15.5.2 40–60 Years
- 15.5.3 Above 60 Years
- 15.6.1 UAE
- 15.6.2 Saudi Arabia
- 15.6.3 South Africa
- 15.6.4 Egypt
- 15.6.5 Israel
- 15.6.6 Morocco
- 15.6.7 Rest of Middle East and Africa
- 15.7 Middle East and Africa Global Fecal Occult Testing Market – Opportunity Analysis Index, By Test Type, By Sample Collection Method, By End User, By Test Mode, By Age Group, and Country, 2024 - 2031
- 15.8 Regional Trends Analysis
- 15.9 Middle East and Africa Global Fecal Occult Testing Market Research Report - Company Profiles
- 15.9.1 Company 1 (UAE)
- 15.9.2 Company 2 (Saudi Arabia)
- 15.9.3 Company 3 (Saudi Arabia)
- 16.1 Strategic Dashboard of Top Market Players
- 16.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
- 16.2.1 Abbott Laboratories
- 16.2.2 Siemens Healthineers
- 16.2.3 F. Hoffmann-La Roche Ltd
- 16.2.4 Quest Diagnostics
- 16.2.5 Epigenomics AG
- 16.2.6 Eiken Chemical Co.
- 16.2.7 Ltd.
- 16.2.8 Sysmex Corporation
- 16.2.9 Beckman Coulter (Danaher Corporation)
- 16.2.10 Hemosure Inc.
- 16.2.11 Polymedco Inc.
- 16.2.12 Alpha Laboratories
- 16.2.13 Bio-Rad Laboratories
- 16.2.14 Inc.
- 16.2.15 Meridian Bioscience
- 16.2.16 Inc.
- 16.2.17 Immunostics Inc.
- 16.2.18 and QuidelOrtho Corporation.
- 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 17. Data Collection Method and Research Approach
- 18. Principal Presumptions and Acronyms